Table 2.
Group | Transition Interval | ||||||||
---|---|---|---|---|---|---|---|---|---|
0–3 months | 3–6 months | 6–12 months | Across all transitions | ||||||
| |||||||||
RMDQ | |||||||||
| |||||||||
Symptom improvement | TAU | 0.14 | * | 0.25 | 0.29 | 0.22 | |||
Intervention | 0.27 | 0.25 | 0.29 | 0.27 | |||||
| |||||||||
Sustained reduction | TAU | 0.81 | 0.80 | 0.80 | 0.81 | ||||
Intervention | 0.81 | 0.85 | 0.83 | 0.81 | |||||
| |||||||||
PHQ-9 | |||||||||
| |||||||||
Symptom improvement | TAU | 0.23 | ** | 0.39 | * | 0.30 | * | 0.31 | * |
Intervention | 0.43 | 0.48 | 0.35 | 0.43 | |||||
| |||||||||
Sustained reduction | TAU | 0.78 | 0.93 | 0.87 | * | 0.85 | * | ||
Intervention | 0.83 | 0.94 | 0.95 | 0.91 | |||||
| |||||||||
CPG Pain Intensity | |||||||||
| |||||||||
Symptom improvement | TAU | 0.08 | * | 0.13 | 0.15 | 0.12 | ** | ||
Intervention | 0.16 | 0.19 | 0.13 | 0.16 | |||||
| |||||||||
Sustained reduction | TAU | 0.50 | ** | 0.68 | 0.61 | ** | 0.60 | ** | |
Intervention | 0.70 | 0.67 | 0.79 | 0.73 | |||||
| |||||||||
CPG Pain Interference | |||||||||
| |||||||||
Symptom improvement | TAU | 0.32 | * | 0.31 | 0.31 | 0.31 | * | ||
Intervention | 0.44 | 0.39 | 0.39 | 0.41 | |||||
| |||||||||
Sustained reduction | TAU | 0.68 | ** | 0.70 | 0.74 | 0.70 | |||
Intervention | 0.83 | 0.75 | 0.77 | 0.78 |
n = 1127 transition intervals.
Symptom improvement: move from higher to lower symptom state
Sustained reduction: remain in lower symptom state
TAU: Treatment as usual
RMDQ: Roland-Morris Disability Questionnaire; higher state ≥14
PHQ-9: Patient Health Questionnaire for depression; higher state ≥11
CPG: Chronic Pain Grade; higher state ≥50
p < 0.05 for comparison between TAU and intervention
p < 0.01 for comparison between TAU and intervention